- Home
- RPTX vs IBG Comparison
RPTX vs IBG Comparison
Compare RPTX & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPTX
- IBG
- Stock Information
- Founded
- RPTX 2016
- IBG 2018
- Country
- RPTX Canada
- IBG Australia
- Employees
- RPTX N/A
- IBG N/A
- Industry
- RPTX Biotechnology: Pharmaceutical Preparations
- IBG Beverages (Production/Distribution)
- Sector
- RPTX Health Care
- IBG Consumer Staples
- Exchange
- RPTX Nasdaq
- IBG Nasdaq
- Market Cap
- RPTX 78.2M
- IBG 75.7M
- IPO Year
- RPTX 2020
- IBG 2024
- Fundamental
- Price
- RPTX $2.15
- IBG $1.82
- Analyst Decision
- RPTX Strong Buy
- IBG Strong Buy
- Analyst Count
- RPTX 3
- IBG 1
- Target Price
- RPTX $3.50
- IBG N/A
- AVG Volume (30 Days)
- RPTX 670.4K
- IBG 122.9K
- Earning Date
- RPTX 11-14-2025
- IBG 11-28-2025
- Dividend Yield
- RPTX N/A
- IBG N/A
- EPS Growth
- RPTX N/A
- IBG N/A
- EPS
- RPTX N/A
- IBG N/A
- Revenue
- RPTX $11,870,000.00
- IBG $2,931,243.00
- Revenue This Year
- RPTX N/A
- IBG N/A
- Revenue Next Year
- RPTX N/A
- IBG N/A
- P/E Ratio
- RPTX N/A
- IBG N/A
- Revenue Growth
- RPTX N/A
- IBG N/A
- 52 Week Low
- RPTX $0.89
- IBG $1.48
- 52 Week High
- RPTX $4.07
- IBG $9.85
- Technical
- Relative Strength Index (RSI)
- RPTX 71.99
- IBG 32.91
- Support Level
- RPTX $1.65
- IBG $1.68
- Resistance Level
- RPTX $1.87
- IBG $2.08
- Average True Range (ATR)
- RPTX 0.08
- IBG 0.32
- MACD
- RPTX 0.01
- IBG -0.17
- Stochastic Oscillator
- RPTX 91.04
- IBG 5.63
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.